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Abstract.  Transforming growth factor-# (I'GF-#) is a 
potent regulator of cell proliferation and modulates the 
interactions of cells with their extracellular matrix 
(ECM), in part by inducing the synthesis of various 
ECM proteins.  Three different isoforms of TGF-/$ are 
synthesized in a defined pattern in specific cell popula- 
tions in vivo. In the specific case of TGF-fll, this well- 
defined and limited expression stands in sharp contrast 
to its synthesis by virtually all cells in culture. 
Using mammary epithelial cells as a model system, 
we evaluated the substratum dependence of the expres- 
sion of TGF-/31. The level of TGF-fll  expression is 
high in cells on plastic, but is strongly downregulated 
when cells are cultured on a reconstituted basement 
membrane matrix.  In contrast,  TGF-fl2 mRNA levels 
in cells on either substratum remain unchanged.  Using 
the chloramphenicol acetyl transferase gene as reporter 
gene under the control of the TGF-/31 promoter,  we 
show that transcription from this promoter is suppressed 
when the cells are in contact with either endogenously 
synthesized or exogenously administered basement 
membrane.  TGF-/$1 promoter activity is strongly in- 
duced by the absence of basement membrane,  i.e., by 
direct contact of the cells with plastic. This modulation 
of transcription  from the TGF-fll promoter occurs in 
the absence of lactogenic hormones which allow full 
differentiation.  Our results thus indicate that basement 
membrane is an important regulator of TGF-B 1 syn- 
thesis, and explain why most cells in culture on plastic 
express TGF-/~I  in contrast with the more restricted 
TGF-/~I  synthesis in vivo. We propose that there is a 
feedback loop whereby "I'GF-/~l-induced  synthesis of 
basement membrane components is repressed once a 
functional basement membrane is present. Finally, these 
results together with our current knowledge of regula- 
tion of TGF-/~I  and TGF-fl2 synthesis, suggest that,  in 
vivo, TGF-/31 may play a major role in regulating the 
ECM synthesis and the ceI1-ECM interactions, whereas 
TGF-/Y2 may be more important in morphogenetic 
processes. 
M 
UCH attention  has  been focused in  recent years 
on the biology of transforming  growth factor-fl 
(TGF-fl),* a potent regulator of cell proliferation. 
TGF-/$ can exert a variety of effects, depending on the nature 
of the target cell and the physiological  conditions.  It stimu- 
lates the proliferation  of  many cell types ofmesenchymal ori- 
gin, yet is growth inhibitory for many other cell types. A ma- 
jor activity of TGF-fl is its ability to stimulate the synthesis 
and deposition of various extracellular  matrix (ECM) pro- 
teins and to increase the expression of integrins,  receptors 
that mediate cellular interactions  with ECM proteins.  This 
is frequently accompanied by an increased synthesis of pro- 
tease inhibitors  and a repression of the synthesis  of ECM- 
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degrading  proteases  (for review see Roberts and  Sporn, 
1990). Taken together, these activities can result in increased 
celI-ECM  interactions  and  adhesiveness.  In  comparison 
with other secreted factors, TGF-/~ can be considered as the 
most potent regulator known to date of ECM formation and 
celI-ECM interactions. 
Our current knowledge of the localization  and biological 
activities of TGF-fl suggests that it exerts its activities in the 
context of organ and tissue remodeling (Heine et al.,  1987; 
Thompson et al., 1989; Fitzpatrick et al., 1990; Gatherer et 
al., 1990; Millan et al., 1990; Pelton et al., 1990a,b, 1991; 
Schmid et al,, 1990). This implies that TGF-/5 may function 
as a physiological regulator of woundhealing,  developmental 
tissue differentiation  and morphogenesis, and tumor devel- 
opment. Since most cells have the capacity to express and 
secrete  TGF-fl  and  have  cell  surface  TGF-fl  receptors 
(Roberts  and  Sporn,  1990),  it is  generally  believed that 
TGF-fl exerts  its  role by autocrine and paracrine  mecha- 
nisms. In addition,  since TGF-fl binds to several ECM pro- 
teins and since ECM contains TGF-/3, it can be assumed that 
the ECM and especially the basement membranes represent 
a reservoir from which TGF-fl can be retrieved so that it can 
exert its various  activities  on the surrounding  cells. 
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terized by cDNA cloning.  Three different TGF-B isoforms, 
each encoded by separate genes, are expressed in mammalian 
call  systems.  These  TGF-B  species have a  high  degree of 
structural identity in their mature polypeptide sequences and 
have similar  biological activities in culture.  Their cellular 
synthesis is subject to differential  regulation  and they are 
differentially  localized  in  vivo.  In  situ  hybridization  and 
isoform-specific immunohistochemistry of the TGF-~I, -/52, 
and -/~3 mRNAs and proteins have documented that the three 
TGF-B species have a well-defined and characteristic expres- 
sion pattern during murine development (Heine et al., 1987; 
Thompson et al.,  1989; Fitzpatrick et al.,  1990; Gatherer et 
al.,  1990; Millan et al.,  1990; Pelton et al.,  1990a,b,  1991; 
Schmid et al.,  1990).  Their cell and tissue distribution  is 
partially overlapping, frequently resulting in the expression 
of more than a single TGF-/~ form in specific cells and tis- 
sues.  This  localized  expression  pattern  of the  individual 
TGF-/3 forms is also reflected to some degree in cells in cul- 
ture. TGF-/T2 and -B3 expression by cells in culture is appar- 
ent only in select cell lines and primary cultures, which are, 
as far as can be assessed, in accordance with cell types nor- 
mally expressing these TGF-/3 species in vivo. In contrast, 
the expression pattern of TGF-B1  in cultured cells clearly 
contradicts the localized TGF-B1 expression in vivo. For ex- 
ample,  during  mouse development TGF-B1  expression oc- 
curs mainly in cell types of  hematopoietic origin, endothelial 
cells and epithelia,  especially in skin.  Yet,  cell culture ex- 
periments indicate that virtually all cells synthesize TGF-/~I 
in culture,  in disagreement with the findings in vivo. 
In this study, we sought to understand the basis of the dis- 
crepancy between the virtually universal expression of TGF- 
ffl in cultured cells and its localized expression in vivo. In 
particular, we have paid attention to the influence of the sub- 
stratum on the expression of TGF-B1 by mammary epithelial 
cells. It is indeed conceivable that removal of the cells from 
their  natural  environment  and  especially  the  absence  of 
ECM might contribute to the discrepancy between their be- 
havior in culture and in vivo.  Thus,  we hypothesized that 
ECM itself might be able to regulate TGF-B1 expression, and 
that the absence of a physiological substratum when cells are 
cultured on plastic dishes, which resembles a "wounded" en- 
vironment,  might induce the otherwise suppressed produc- 
tion of TGF-B1. Therefore, it is likely that increased TGF-B1 
synthesis would subsequently induce the secretion and depo- 
sition of several ECM proteins in an autocrine manner, con- 
tributing  to  an  establishment  of more physiological  cell- 
ECM interactions. 
We have evaluated our hypothesis using epithelial cells de- 
rived  from the  mouse mammary  gland.  These  cells have 
been used previously to explore the influence of ECM on the 
regulation of gene expression and differentiation (Lee et al., 
1984,  1985;  Li  et  al.,  1987;  Chen  and  Bissell,  1989; 
Barcellos-Hoff et al.,  1989; Aggeler et al.,  1991;  Schmid- 
hauser et al.,  1990, 1992; Streuli and Bissell,  1990; Streuli 
et al.,  1991).  Our findings document that the absence of a 
basement membrane has a profound and specific effect on the 
expression of TGF-B1, resulting in an upregulation of TGF- 
ffl expression when cells are maintained on plastic as sub- 
stratum.  Using  the TGF-B1  promoter  linked to a  reporter 
gene, we show that this effect is due to an enhanced transcrip- 
tion from the TGF-B1 promoter. The induction of TGF-B1 ex- 
pression in the absence of ECM and its suppression by the 
presence of a basement membrane may provide a feedback 
loop resulting in a balance between TGF-BI expression and 
basement membrane formation. 
Materials and Methods 
Substrata and Cell Culture 
EHS  matrix was  prepared from EHS  tumors passaged  in C57BL mice 
(Kleinman et al., 1986) and used as described (Barcellos-Hoff et al., 1989; 
Streaili et al., 1991). Collagen I was prepared from rat tails (Lee et al., 1984) 
and stored at a concentration of 2-3 mg/ml. Thick collagen gels were made 
with  150 #1 collagen  I  per cm  2 and either left attached to the dish or 
released into the medium 24 h after plating (Streuli and Bissell, 1990). 
Primary mammary epithelial cells were prepared from 14.5-d-pregnant 
CD-1 mice and cultured on physiological substrata in the presence of insulin 
(5 #g/ml) and lactogenic  hormones (1 #g/ml hydrocortisone,  3 t~g/ml pro- 
lactin) as described elsewhere (Lee et aL,  1985; Emerman et al.,  1988; 
Streuli et al.,  1991). The mouse IDamrnary epithelial cell line CID-9 and 
its transfected derivatives  were cultured routinely in DME/FI2 medium 
containing 5% FCS and 5 #g/ml insulin (Schmidhauser et al.,  1990).  For 
CAT assays and differentiation assays, these cells were plated onto relevant 
substrata and cultured with 2 % serum for 24 h.  The medium was then 
changed to serum-free DME/FI2 containing insulin and lactogenic  hor- 
mones as above, and the cells were fed every 2 d. 
mRNA Analysis 
RNA was extracted from tissues and cultured cells by the gnanidinium  thio- 
cyanate method as described (Sambrook et al., 1989). Folyadenylated RNA 
was isolated by adsorption to oligo d(T)-ce]lniose  (Sambrook et al., 1989). 
Northern analysis for the presence of specific mRNAs was done as follows. 
Total RNA was electrophoresed  in 1% agarose, 5 % formaldehyde gels, fol- 
lowed by etectrotransfer to nylon membranes (Oenescreen or Hybond-N) 
and UV cross-linking.  Equal loading was confu'med by comparing intensi- 
fies  of  ethidium bromide-stained  ribosomal  RNAs.  Membranes  were 
probed with TGF-~I  (Derynck et al.,  1986) or -f12 (Miller et al.,  1989) 
specific cDNA fragments 32p-radiolabeled by the random priming method 
(Boehringer  Mannbeim  Corp., Indianapolis,  IN) according to the manufac- 
turer's directions.  All hybridizations were performed under high stringency 
conditions (Derynck et al.,  t988).  Unhybridized probe was removed by 
washing membranes with O.1x SSC, 0.2% SDS at 60~ 
Quantitation of TGF-[3 Secretion 
The conditioned medium of cultured ceils was collected and assayed for 
TGF-/~-induced inhibition of proliferation of CCL64 mink lung cells with 
or without acid activation,  as previously  described (Arrick et al.,  1990; 
Meager,  1991). 
TGF-[31 Promoter-CAT Expression Plasmid 
The  1,373-bp  BamHI-SacII restriction fragment containing the TGF-B1 
promoter and the first 11 bp of the long 5' untranslated region (Kim et al., 
1989) was isolated from the recombinam k-phage BMA1, which carries the 
first exon of the human TGF-BI precursor gene (Derynck et al., 1987). This 
restriction fragment was placed upstream of the sequence coding for the 
CAT coding sequence in such a way that the ATG initiator codon followed 
the SaclI recognition site by only four basepalrs: CCGCGG CAAA ATG. 
The sequence immediately preceding the ATG was designed to achieve an 
optimal translation  efficiency (Kozak, 1989). This sequence context was in- 
troduced by site-directed  mutagenesis on the template incorporated into 
M13 mpl8 as described (Zoller and Smith, 1984). All sequences were deter- 
mined using the dideoxy sequencing method on single-stranded templates 
(Sambrook  et al., 1989). The final plasmid pBIP-CAT  incorporated the tran- 
scription unit linking the TGF-B1 promoter to the CAT coding sequence, 
in the same plasmid background as the plasmid S/A-CAT (Jakobovits et al., 
1988). 
Transformations and Selection 
Rapidly growing CID-9 cells were transfected with pBIP-CAT by the cal- 
cium phosphate procedure (Sambrook et al.,  1989). 40 #g plasmid DNA 
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transfected cells were selected using  400 ~g G418/ml medium. After 4 wk, 
surviving clones  were  pooled and expanded. Cells were  plated at equal den- 
sity (6.2 x  104 per cm  2) on plastic culture dishes, on Engelbreth-Holm- 
Swarm (EHS) matrix, or on collagen  I gels for various assays as described 
previously (Schmidhauser et al.,  1990). 
CAT Assays 
To measure the CAT enzyme levels, as an indication of promoter activity, 
expressed from the TGF-/~I promoter in transfected cells cultured under 
different conditions, cells were harvested with dispase (40-60 win, 37~ 
washed to remove  dispase, lysed in 0.5% NP-40  and further solubilized by 
freeze thawing. To normalize the extracts, cell protein was quantified in a 
micro Bradford assay; excess EHS matrix which would interfere with the 
protein assay was removed efficiently by the dispase treatment. Aliquots 
representing equal amounts of  total cell protein (10 #g) were incubated  with 
14C-chioramphenicol (0.1 #Ci) and acetyl coenzyme  A (70 #g) for 6 h at 
37~  extracted with ethyl acetate and separated by TLC. The levels of 
acetylated chioramphenicol were quantitated by scraping the radioactive 
spots from the TLC plate and counting  in a scintillation counter (Sambmok 
et ai., 1989). All measurements were done in duplicate and the difference 
between the duplicate values was <5%. 
Protein Assays 
To confirm  that the cell lysates had been normalized correctly, 3 #g of the 
cell protein from CAT assay  lysates were separated on reducing  SDS-poly- 
acrylawide gels and then stained with silver. Western blotting was per- 
formed by separating 1 #g of  cell protein on reducing SDS-polyacrylamide 
gel, transferring the protein onto Immobilon-P transfer paper, and then 
probing the blot with an antibody that recognizes a spectrum of mouse 
caseins (Lee et al.,  1985). 
Results 
ECM-dependent Regulation of TGF-fll mRNA Levels 
To assess whether TGF-/?I was expressed by mammary gland 
and whether its expression was developmentally regulated, 
the steady-state levels of mRNA from glands of CD-1 mice 
at different stages of the pregnancy cycle were compared by 
Northern analysis (Fig.  1). The presence of TGF-/31 mRNA 
was apparent  in the mammary tissue of nonpregnant mice 
(Fig. 1, lane/). During two periods of active tissue remodel- 
ing, i.e., during pregnancy (Fig.  1, lane 2) and gland involu- 
tion  after  lactation  (Fig.  1,  lane  4),  the  level  of TGF-fll 
mRNA in the nmmnmry gland was more abundant. In con- 
trast,  TGF-fll  mRNA  levels  were  downregulated  during 
lactation  when milk is being  synthesized;  at  this  stage no 
TGF-/Yl  transcripts  were detected in Northern blots of un- 
Figure 2.  TGF-/~I mRNA is 
upregulated  in cells  cultured 
on  plastic  dishes.  RNA was 
prepared  from  midpregnant 
mammary gland (lane 1), and 
from uncultured epithelial cells 
isolated  from the gland (lane 
2). These epithelial cells were 
also plated onto plastic dishes 
(lane 3) or EHS matrix (lane 
4) and cultured for 6 d before 
extracting total RNA. A North- 
era blot of  these RNAs (10 #g) 
was  then  hybridized  with  a 
eDNA for human TGF-fll. 
fractionated mRNA (Fig.  1, lane 3).  Such temporal varia- 
tions during development of the mammary gland also occur 
with the expression of TGF-/~2 and -f13 mRNA (Robinson et 
al.,  1991). 
The presence  of TGF-/~I  transcripts  in mammary gland 
prompted us to ask whether any of the TGF-fl species were 
expressed by primary epithelial cells in culture. The epithe- 
lied cell component of the mammary glands of mid-pregnant 
mice were separated from adipose and stromed tissue by col- 
lagenase  digestion,  followed by  differential  centrifugation 
(Lee et al., 1985; Emerman and Bissell,  1988; Streuli et al., 
1991).  TGF-fll  mRNA was clearly present in these uncul- 
tured epithelial  cells  (Fig.  2,  lane 2).  The higher level  of 
"IGF-fll mRNA from undigested gland tissue (Fig.  2,  lane 
2)  presumably  reflects  a  significant contribution  from the 
stromed tissue, which was removed during the epithelial cell 
isolation  procedure.  Experiments  with  epithelium-free 
mammary fat pads have confirmed that,  indeed,  the mam- 
mary stroma does express significant quantities  of TGF-fll 
during pregnancy (Robinson et al.,  1991). 
Polyadenylated mRNA was then prepared  from cultured 
cells and was shown to contain TGF-ffl and TGF-B2 tran- 
scripts (Fig. 3). TGF-fl3 was barely detectable (not shown). 
Because  considerable  phenotypic  changes  occur in  mam- 
mary epithelial cells cultured on different substrata (Aggeler 
Figure I. The levels of  TGF-/J 1 
mRNA are modulated during 
the  pregnancy  cycle.  Total 
RNA was extracted  from the 
mammary glands of 8-wk-old 
virgin mice (lane 1), and from 
the glands of 14.5-d-pregnant 
(lane  2),  2-d-lactating  (lane 
3),  and  5-d-involuting  mice 
(lane  4).  10  #g  RNA,  sep- 
arated in 1% agarose-formal- 
dehyde gels,  was  transferred 
to nylon membranes and the 
resulting  Northern  blot  was 
hybridized with a  eDNA for 
human TGF-31. 
Figure 3. Expression of  TGF-31, but not TGF-fl2, is substratum  de- 
pendent. Northern blots of  polyadenylated mRNAs (10/~g) isolated 
from primary mouse mammary epithelial-cells  that had been cul- 
tured for 6 d either on plastic dishes  (lanes  1) or on EHS matrix 
(lanes 2), were probed in parallel with radiolabeled eDNAs coding 
for human TGF-B1 and human TGF-fl2. The four previously identi- 
fied TGF-/?2 transcripts  were evident in mammary epithelial  cells. 
A mouse glyceraldehyde phosphate dehydrogenase eDNA (mGAP) 
provided a suitable  control for confirming equal loading of the two 
different  mRNAs. 
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steady-state levels of TGF-fl mRNAs in cells plated on plas- 
tic dishes (Fig. 3, lanes/) and on a basement membrane- 
rich  matrix derived from EHS  tumour  (EHS  matrix,  or 
"Matrigel") (Fig. 3, lanes 2). When these cells were cultured 
on this matrix, TGF-~  mRNA was drastically reduced in 
comparison with cells on plastic (Fig. 3). The level of TGF- 
/32 mRNA, on the other hand, was unchanged. 
Measurement of TGF-/~ protein levels by a sensitive bioas- 
say was frequently impossible due to the presence of an in- 
hibitor of the assay in the conditioned medium (data not 
shown). In addition, antibody-based TGF-fl assays did not 
provide sufficient sensitivity to measure TGF-/$ levels under 
our conditions. However, when only low levels of this inhibi- 
tor were apparent, it was clear that the levels of total TGF-fl 
(thus  including both  TGF-/31 and  -/32) was  significantly 
higher when the cells were cultured on plastic, compared 
with cells cultured on ECM. As an example, after 3 d the 
concentration of secreted TGF-/$ in the conditioned medium 
was 2.1 ng/ml, when grown on ECM, versus 3.1 ng/ml from 
cells  on plastic.  Between d  3  and  5,  the  cells  on  ECM 
secreted 1.3 ng/ml TGF-/~, whereas cells on plastic produced 
5.7  ng/ml TGF-/3. In yet another experiment, the level of 
TGF-/$ expressed by the cells on plastic was 2.1-fold higher 
than the TGF-/~ secreted by the cells on EHS matrix. Thus, 
although it was not possible to discriminate between both 
TGF-/3 isoform protein levels, our mRNA and protein results 
do demonstrate that these different substrata have dramatic 
and specific effects  on the expression of TGF-/Sq, but not 
TGF-I$2 mRNAs. We know from previous studies (Li et ai., 
1987; Barcellos-Hoff  et al., 1989), which are also confirmed 
here (see below), that milk protein expression is induced on 
the basement membrane matrix and inhibited on plastic. 
Functional differentiation into polarized milk secreting cells 
and TOF-/$1 expression are therefore regulated in opposite 
directions. 
To ask whether culturing the cells on plastic induced TGF- 
/31  expression or whether ECM  inhibited expression,  we 
compared TGF-ffl mRNA levels in isolated mammary epi- 
thelial cells before cell culture with those cultured on either 
plastic or on EHS matrix (Fig.  2,  lanes 3  and 4,  respec- 
tively). The TGF-ffl mRNA level  in the cells cultured on 
EHS matrix was similar to that in uncultured cells and was 
not inhibited. However,  the much higher TGF-ffl mRNA 
level in cells cultured on plastic stands in sharp contrast with 
that in uncultured cells. Thus the absence of a suitable ECM 
as substratum resulted in an increased TGF-~ expression, 
whereas  culture  of the  epithelial  cells  on  the  basement 
membrane-rich EHS matrix maintained the TGF-/31 expres- 
sion at similar levels to those seen in vivo. 
ECM Regulates TGF-[31 Expression at the 
Transcriptional Level 
To evaluate whether this substratum dependence was a result 
of transcriptional regulation, we measured the expression of 
an easily assayable reporter gene under the control of the 
TGF-/~I promoter. We isolated a restriction fragment con- 
taining the TGF-/31 promoter  (Kim et al.,  1989)  from a 
recombinant phage containing the first exon of the human 
TGF-/~I gene (Derynck et al., 1987).  Previous studies have 
shown a high degree of sequence conservation between the 
human and mouse TGF-/31 promoters and especially their 
putative regulatory  sequences  (Geiser  et al.,  1991). The 
1,373-bp  BamI-l/-SaclI fragment containing the promoter 
region and the first 11 bp of the 5' untranslated region was 
linked upstream from the sequence encoding chlorarnpheni- 
col acetyltransferase (CAT). The resulting expression plas- 
mid TGF-fllP-CAT containing the TGF-/31 promoter and 5' 
untranslated sequence fused to the CAT coding sequence was 
then transfected into the mammary epithelial cell line CID-9, 
which has been shown to behave and differentiate very simi- 
laxly to freshly isolated primary mammary epithelial cells 
(Schmidhauser et al., 1990). In addition, these cells also dis- 
played a  downregulated TGF-fll mRNA expression when 
cultured on basement membrane (data not shown). Cotrans- 
fection of the TGF-/31 promoter plasmid with a neomycin- 
resistance encoding plasmid pSV2-Neo allowed the selection 
and generation of stable transfected cell clones, that con- 
tained integrated pTGF-fllP-CAT sequences. 
The  stable transfected cell lines were then cultured on 
plastic culture dishes for 6 d and compared with those on 
EHS matrix. The levels of accumulated CAT enzyme, ex- 
pressed from the TGF-/31 promoter, were quantitated using 
the  standard  assay  for  ~4C-chloramphenicol  conversion 
(Fig. 4, lanes I  and 2). There was a considerable difference 
in the CAT enzyme levels (10-13 times more CAT enzyme 
in cells cultured on plastic), and thus in the TGF-fll promoter 
activity, in the ceils cultured on the two types of substrata. 
The lack of extracellulax matrix therefore results in a dra- 
matic increase of transcription from the TGF-fll promoter, 
and the difference in TGF-fll mRNA levels between cells cul- 
tured on plastic and ECM is due largely to differences in 
transcriptional activity. 
Basement Membrane Itself Provides Signals to 
Regulate TGF-(31 Expression 
The pTGF-/31P-CAT plasmid transfected CID-9 cells used 
above had been cultured so far in the presence of lactogenic 
hormones, prolactin and hydrocortisone. However, the com- 
bined presence of both these components and EHS matrix 
results in the acquisition of a differentiated phenotype char- 
acteristic of mammary epithelial cells in vivo. A marker of 
this differentiated phenotype is  the expression of caseins 
which constitute the major proteins  in milk.  To examine 
whether the low expression from the TGF-/31 promoter is 
related to functional differentiation or is solely the result of 
cultivation on ECM, the transfected cells were cultured on 
plastic or on ECM in the absence of  prolactin and hydrocorti- 
sone  (Fig.  4,  lanes  3  and  4).  There  was  no  functional 
differentiation  under these conditions, as assessed by the ab- 
sence of caseins.  However,  CAT enzyme accumulated to 
similar levels in either the presence or absence of the lacto- 
genie hormones. Thus, the difference in transcription from 
the  TGF-ffl  promoter  is  not linked to  the  acquisition of 
differentiation-specific functions per se, but is solely a re- 
sponse to the nature of the substratum. 
An explanation for the effect of the substrata might be that 
the mammary epithelial cells on ECM or plastic secrete a 
factor that influences the level of TGF-fll promoter activity. 
It is for example known that conditioned medium from mam- 
mary cells cultured on plastic suppresses the synthesis of one 
of the milk proteins, whey acidic protein (Chen and Bissell, 
1989).  A simple experiment was therefore performed to see 
whether secreted factors were responsible for the observed 
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tivity  is  downregulated  on 
floating collagen I gels. p#lP- 
CAT-transfected  cells  were 
cultured  on  thick  collagen  I 
gels for 6  d.  The gels either 
were left attached to the cul- 
ture  dish  (lanes  1)  or  were 
floated into the medium after 
2 d (lanes 2). Total cell protein 
was  then  separated  for  (A) 
CAT  assays  of  TGF-/~  pro- 
moter activity, or (B) Western blotting with a casein-specific anti- 
body. In the experiment inA, the levels of acetylated chlorampherti- 
col expressed as cpm per/~g cell protein per min enzymatic reaction 
time (total reaction time was 6 h) were as follows:  (lane 1) 7.76; 
(lane 2) 0.28. 
Figure 4.  ECM  controls  the  activity  of the  TGF-/~I  promoter. 
Pooled clones of CID-9 ceils,  stably transfected with p/~IP-CAT, 
were plated at equal density (6.2  x  104 per cm  z) on plastic culture 
dishes (lanes 2, 4, 6, and 8) or on EHS matrix (lanes 1, 3, 5, and 
7). The cells were then cultured either with (lanes 1, 2, and 5-8) 
or without (lanes 3 and 4) prolactin. In one experiment (lanes 5-8), 
medium conditioned  from cells cultured  on plastic dishes or on 
EHS matrix was added for 4 d; this medium was either added back 
to the homologous dishes (lanes 5 and 6) or to the converse culture 
conditions (lanes 7and 8). (A) CAT assays of TGF-/~I promoter ac- 
tivity in the cells cultured under these different conditions. In this 
experiment the levels of acetylated chloramphenicol expressed as 
cpm per #g cell protein per min enzymatic reaction time (total re- 
action time was 6 h) were as follows:  (lane 1) 0.21; (lane 2) 2.09; 
(lane 3) 0.26; (lane 4) 3.27;  (lane 5) 0.24;  (lane 6) 2.20;  (lane 7) 
0.16; and (lane 8) 1.54. (B) Cell proteins separated by polyacryla- 
mide gel electrophoresis and stained with silver confirmed that the 
ceil lysates indeed had been normalized correctly, and showed that 
only on the EHS matrix and only in the presence of prolactin (lanes 
1, 5, and 7) were substantial amounts of/~-casein synthesized. (C) 
That these bands were actually casein was shown by Western blot- 
ting 1/~g of ceil protein onto Immobilon-P transfer paper, and then 
probing the blot with an antibody that recognizes a  spectrum of 
mouse caseins. 
modulation  of TGF-~  expression.  The transfected  CID-9 
cells were cultured  in the presence of conditioned  medium 
from cells  on  either  plastic  dishes  or the basement mem- 
brane EHS matrix in the presence of lactogenic  hormones 
(Fig.  4,  lanes 5-8).  CAT assays and parallel casein  assays 
showed that the TGF-/31 promoter activity was not affected 
by these different conditioned media, and,  thus,  did not de- 
pend on the presence of secreted  soluble  factors. 
Formation of  an Endogenous Basement Membrane 
Downregulates TGF-[31 Promoter  Activity 
We have shown previously that the differentiation  of mam- 
mary ceils that occurs as a result of cultivation on a floating 
type I collagen substratum,  correlates with the formation of 
an  endogenous  basement  membrane  (Streuli  and  Bissell, 
1990). We therefore evaluated the influence of collagen type 
I matrix on TGF-/5'I promoter activity in the presence of lac- 
togenic hormones.  If downregulation  of TGF-/31 expression 
on EHS matrix is due to the presence of basement membrane 
components,  transcription  from  the  TGF-~I  promoter 
should be reduced  after flotation of the collagen I  gel.  On 
attached  collagen  I  gels,  CID-9  cells  behave  similarly  to 
those on plastic; in addition, they do not differentiate and do 
not  synthesize  a  basement membrane  (Streuli  and  Bissell, 
1990).  This is in contrast to their behavior on floating colla- 
gen I gels, where the cells contract the gel and synthesize a 
basement  membrane,  and,  as  a  result  of  these  changes, 
differentiate  and  secrete milk proteins.  Under these condi- 
tions, the formation of a basement membrane can be demon- 
strated  by  immunostaining.  The  transfected  CID-9  cells 
were  therefore  cultured  on  attached  or floating  collagen  I 
gels and the CAT activities directed  from the TGF-/~I pro- 
moter were measured.  The cells on attached  collagen gels 
displayed a high level of promoter activity, analogous to cells 
on plastic,  whereas on the floating gels,  the cells exhibited 
a greatly suppressed promoter activity as seen with cells on 
EHS matrix (Fig.  5).  Thus, as with an exogenous basement 
membrane, the presence of an endogenous basement mem- 
brane  suppresses  the  transcription  from  the  TGF-/31  pro- 
moter.  Since we have already shown that such suppression 
of the promoter is not dependent on the differentiated pheno- 
type,  we can  conclude  that  the  basement membrane  itself 
provides  signals  to regulate  TGF-/31 transcription. 
Discussion 
In this study, we have established that expression of the TGF- 
/~1 gene is regulated negatively by extraceUular matrix. Tran- 
scription from the TGF-/31 promoter is high in the absence 
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matrix  or  an  endogenously  synthesized basement  mem- 
brane.  The much lower TGF-BI  promoter activity in the 
presence of  basement membrane is not a result of differentia- 
tion per se, since inhibition of functional differentiation (by 
removing lactogenlc hormones) does not alter TGF-/3 pro- 
moter activity. This type of regulation of TGF-/3 expression 
is specific for TGF-/31 since the level of TGF-/32 mRNA in 
the same epithelial cells is not affected by the absence of 
ECM. 
An evaluation of the available data on TGF-/31 expression 
by different cell types reveals a major discrepancy between 
the TGF-/31 synthesis in vivo and in cell culture. In vivo, only 
a defined subset of  cell populations expresses TGF-/31 (Wilcox 
and Derynck, 1988; Thompson et al., 1989; Fitzpatrick et 
al., 1990; Gatherer et al., 1990; MiUan et al., 1990; Pelton 
et al., 1990a,b, 1991; Schmid et al., 1990), whereas in cul- 
ture its expression is virtually ubiquitous. On the basis of  our 
current data,  we believe that this discrepancy can be ex- 
plained by the presence or absence of basement membrane, 
since the absence of ECM results in a significant increase in 
TGF-BI  expression.  There  is  considerable  evidence that 
TGF-/3 is able to induce the synthesis of various ECM pro- 
teins (Massagur  1990; Roberts and Sporn, 1990; Kahari et 
al., 1991). Also manunm~ cells cultured on plastic substra- 
tum produce high levels of ECM proteins (Streuli and Bis- 
sell, 1990), which may be a result of  the high level of  TGF-BI 
expression. Thus, the absence of ECM induces TGF-/31 ex- 
pression which in turn stimulates the synthesis of ECM pro- 
teins in an autocrine fashion. We have now documented that, 
once the  ECM  is  deposited,  TGF-B1 gene expression  is 
strongly downregulated. This may explain the base-line ex- 
pression of ECM proteins we observe when cells synthesize 
an endogenous basement membrane (Streuli  and Bissell, 
1990).  It is thus possible that some type of ECM-induced 
negative feedback loop regulates TGF-/31 expression. 
Our results also indicate that caution has to be exercised 
when evaluating the physiological relevance of TGF-/S'I syn- 
thesis using cells cultured in the absence of basement mem- 
brane, i.e., the commonly used cell culture conditions. The 
expression of various ECM proteins and proteins involved in 
ceU-matrix interactions, such as proteases, protease inhibi- 
tors and integrins, is strongly modulated by TGF-/3. It is thus 
conceivable that their expression levels may be dependent 
upon  the  autocrine  control  of endogenously synthesized 
TGF-/3, as we have recently demonstrated for a TGF-/31 over- 
expressing tumor cell line (Arrick et al.,  1992).  Thus, the 
enhanced TGF-/31 synthesis in the absence of ECM may also 
affect  the levels of synthesis of  these proteins under autocrine 
control of TGF-B, resulting in expression levels which are 
not representative of the physiological conditions in vivo. 
We have shown that the presence of EHS matrix, a base- 
ment membrane preparation, and an endogenously synthe- 
sized basement membrane keep the TGF-/31 in an uninduced 
state, while a type I collagen matrix by itself does not down- 
regulate TGF-/31 expression. Which component of the base- 
ment membrane affects  TGF-/31 expression is unknown at 
present. It is, however, likely that the responsible factor must 
be deposited in an insoluble form in the basement mem- 
brane, since the conditioned medium from cells on plastic, 
which contains a variety of soluble ECM proteins, did not 
affect the TGF-B1 promoter activity. However,  if a  simple 
negative feedback mechanism exists, it is likely that an ECM 
component whose expression is under control of TGF-B is 
responsible for the downregulation of TGF-~I expression. 
The mechanism by which the cell recognizes the absence or 
the  presence  of ECM  is  presumably based  on  signaling 
through cell surface receptors  for the appropriate matrix 
components. Occupation of the receptors would then result 
in a repressed transcriptional activity, whereas the TGF-/31 
transcription would be induced in the absence of the ligand. 
It has been established already that ECM components can 
influence gene expression.  Our  previous  work using the 
same mammary epithelial cells has shown that cell-ECM in- 
teractions in the absence of cell-cell interaction and polarity 
is sufficient to induce expression of B-casein and that this in- 
duction of gene expression requires a signal transfer medi- 
ated through integrins (Streuli et al.,  1991). In addition, 
interaction between the cells and the ECM, and more ex- 
plicitly integrin-mediated interaction with fibronectin frag- 
ments, induces collagenase and stromelysin gene expression 
(Werb et al.,  1989).  Our current study indicates that base- 
ment membrane has the ability to modulate the transcription 
of TGF-/~I, a factor that determines the cell-matrix interac- 
tion. On the basis of this finding, it would be no surprise if 
the expression of other regulators of cell-matrix interac- 
tions,  such as  the bone morphogenetic proteins or other 
members of the TGF-B superfamily, also would be modu- 
lated by cell-ECM interactions. 
The transcription and mRNA levels of TGF-/31, -/32, and 
-B3 are differentially  regulated and this is presumably related 
to their different promoter structures. Since the expression 
of TGF-~, and not TGF-/~2, is strongly affected by ECM, 
it is likely that this specific modulation is related to the pres- 
ence of a TGF-~I specific promoter element that is absent in 
the TGF-/$2 promoter, e.g., an AP-1 site (Malipiero et al., 
1990).  We have recently demonstrated the presence of an 
ECM-responsive enhancer in the 5' region of the B casein 
promoter (Schmidhauser et al., 1992).  The best inducer of 
TGF-/32 and -/33 currently known is retinoic acid (Glick et 
al., 1989). Whereas TGF-/32 mRNA levels can be enhanced 
up to 10-30-fold by retinoic acid, the level of  TGF-B1 mRNA 
is increased only 1.5-3-fold. These studies, however,  were 
performed using cells cultured on plastic substratum, result- 
ing in an already high level of TGF-/~I transcription in un- 
treated cultures; it is therefore possible that a greater differ- 
ence could be observed if cells were cultured on ECM. The 
only  dramatic  induction  of  TGF-/~I mRNA  expression 
reported so far has been the auto-induction of TGF-/31 by 
TGF-/$ itself (Van Obberghen-Schilling et al., 1988; Bascom 
et al.,  1989).  We now show that a dramatic difference in 
TGF-/$ expression can be achieved also by the absence or 
presence of ECM. These findings suggest that both the levels 
of active TGF-/~I, as weft as the cell-ECM interactions may 
be major determinants of the rates of TGF-~I synthesis by 
epithelial and other cells in vivo. 
The regulation of TGF-B1 and not TGF-/~2 expression by 
ECM suggests  that these two TGF-/3 forms have different 
normal physiological roles in vivo.  The regulation of TGF- 
B2 by retinoids (and steroids) suggests that TGF-B2 may play 
a role in various differentiation  and morphogenetic processes 
during development. On the other hand, TGF-/31 expression 
in vivo may be important in the deposition and establishment 
of basement membrane and extracellular matrix. In addi- 
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localized amplification of the TGF-/~I effects. Thus, expres- 
sion of TGF-/31 would be upregulated whenever the interac- 
tion of the cells with the extracellular matrix or basement 
membrane is disturbed, e.g., following wounding (Sieweke 
et al.,  1990). 
In conclusion, our data show that the expression of the 
TGF-/31 gene, but not the TGF-/T2 gene, is strongly affected 
by the absence or presence of ECM and suggests a possible 
feedback loop in vivo, whereby the loss of of the proper cel- 
lular interactions with the ECM induces "I'GF-g/1  expression. 
TGF-/31 then in turn induces the synthesis of several ECM 
proteins. When conditions are right for the ECM compo- 
nents to come together to form a basement membrane, TGF- 
B1 expression is suppressed. Further studies will be needed 
to further define this regulation at the molecular level and to 
understand its relevance in vivo. 
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